Draft Guidance for Industry, User Facilities, and Food and Drug Administration Staff; eMDR-Electronic Medical Device Reporting; Availability, 42310 [E9-19681]

Download as PDF 42310 Federal Register / Vol. 74, No. 161 / Friday, August 21, 2009 / Notices C. Target Audience The course is targeted at healthcare professionals responsible for, or involved in, the conduct and/or design of clinical trials. Dated: August 14, 2009. David Horowitz, Assistant Commissioner for Policy. [FR Doc. E9–20084 Filed 8–20–09; 8:45 am] BILLING CODE 4160–01–S DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2008–D–0395] Draft Guidance for Industry, User Facilities, and Food and Drug Administration Staff; eMDR— Electronic Medical Device Reporting; Availability AGENCY: Food and Drug Administration, HHS. srobinson on DSKHWCL6B1PROD with NOTICES ACTION: Notice. SUMMARY: The Food and Drug Administration (FDA) is announcing the availability of the draft guidance entitled ‘‘eMDR—Electronic Medical Device Reporting.’’ The draft guidance document addresses general issues related to the submission of postmarket medical device reports (MDRs) in electronic format. Elsewhere in this issue of the Federal Register, FDA is publishing a proposed rule to require that manufacturers, importers, and user facilities submit most MDRs to the agency in electronic format. DATES: Although you can comment on any guidance at any time (see 21 CFR 10.115 (g)(5)), to ensure that the agency considers your comment on this draft guidance before it begins work on the final version of the guidance, submit written or electronic comments on the draft guidance by November 19, 2009. ADDRESSES: Submit written requests for single copies of the draft guidance document entitled ‘‘eMDR—Electronic Medical Device Reporting’’ to the Division of Small Manufacturers, International, and Consumer Assistance , Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Ave., Building 66, rm. 4613, Silver Spring, MD 20993– 0002. Send one self-addressed adhesive label to assist that office in processing your request, or fax your request to 301– 847–8149. See the SUPPLEMENTARY INFORMATION section for information on electronic access to the guidance. Submit written comments concerning this draft guidance to the Division of VerDate Nov<24>2008 16:22 Aug 20, 2009 Jkt 217001 Dockets Management (HFA–305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852. Submit electronic comments to https:// www.regulations.gov. Identify comments with the docket number found in brackets in the heading of this document. FOR FURTHER INFORMATION CONTACT: Howard Press, Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Ave., Building 66, rm. 3320, Silver Spring, MD 20993–0002, 301–796–6087. SUPPLEMENTARY INFORMATION: I. Background The draft guidance document provides information related to the submission of postmarket MDRs in electronic format, including technical information. The information provided in the draft guidance document is intended to help reporters prepare the MDR for electronic submission in a way that would satisfy the requirements of FDA’s proposed electronic Medical device reporting regulation that is published elsewhere in this issue of the Federal Register. II. Significance of Guidance This draft guidance is being issued consistent with FDA’s good guidance practices regulation (21 CFR 10.115). The draft guidance, when finalized will represent the agency’s current thinking on electronic medical device reporting (eMDR). It does not create or confer any rights for or on any person and does not operate to bind FDA or the public. An alternative approach may be used if such approach satisfies the requirements of the applicable statute and regulations. III. Electronic Access Persons interested in obtaining a copy of the draft guidance may do so by using the Internet. To receive an electronic copy of ‘‘eMDR—Electronic Medical Device Reporting’’ you may either send an e-mail request to dsmica@fda.hhs.gov or send a fax request to 240–276–3151 to receive a hard copy. Please use the document number 1679 to identify the guidance you are requesting. The Center for Devices and Radiological Health (CDRH) maintains an entry on the Internet for easy access to information including text, graphics, and files that may be downloaded to a personal computer with Internet access. Updated on a regular basis, the CDRH home page includes device safety alerts, Federal Register reprints, information on premarket submissions (including lists of approved applications and manufacturers’ addresses), small PO 00000 Frm 00086 Fmt 4703 Sfmt 4703 manufacturer’s assistance, information on video conferencing and electronic submissions, Mammography Matters, and other device-oriented information. The CDRH Web site may be accessed at https://www.fda.gov/cdrh. A search capability for all CDRH guidance documents is available at https:// www.fda.gov/cdrh/guidance.html. Guidance documents are also available on the Division of Dockets Management Internet site at https:// www.regulations.gov. IV. Paperwork Reduction Act of 1995 This draft guidance refers to proposed collections of information described in FDA’s proposed rule on medical device reporting, electronic submission requirements, published elsewhere in this issue of the Federal Register. The proposed collections of information in the proposed rule are subject to review by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995 (PRA) (44 U.S.C. 3501–3520). In accordance with the proposed medical device regulation, medical device manufacturers, importers, and user facilities would be required to submit MDRs to FDA, to maintain records, and may also seek exemption or variance from these requirements. Manufacturers, importer, and user facilities are currently submitting paper MDR reports on FDA Form 3500 A, for which the existing information collection requirements under 21 CFR part 803 are approved under OMB control number 0910–0437. The changes to the burden associated with this proposed rule have been sent to OMB as a revision to OMB control number 0910–0437 for review under section 307(d) of the PRA. V. Comments Interested persons may submit to the Division of Dockets Management (see ADDRESSES), written or electronic comments regarding this document. Submit a single copy of electronic comments or two paper copies of any mailed comments, except that individuals may submit one paper copy. Comments are to be identified with the docket number found in brackets in the heading of this document. Received comments may be seen in the Division of Dockets Management between 9 a.m. and 4 p.m., Monday through Friday. Dated: August 11, 2009. Jeffrey Shuren, Associate Commissioner for Policy and Planning. [FR Doc. E9–19681 Filed 8–20–09; 8:45 am] BILLING CODE 4160–01–S E:\FR\FM\21AUN1.SGM 21AUN1

Agencies

[Federal Register Volume 74, Number 161 (Friday, August 21, 2009)]
[Notices]
[Page 42310]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-19681]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2008-D-0395]


Draft Guidance for Industry, User Facilities, and Food and Drug 
Administration Staff; eMDR--Electronic Medical Device Reporting; 
Availability

AGENCY:  Food and Drug Administration, HHS.

ACTION:  Notice.

-----------------------------------------------------------------------

SUMMARY:  The Food and Drug Administration (FDA) is announcing the 
availability of the draft guidance entitled ``eMDR--Electronic Medical 
Device Reporting.'' The draft guidance document addresses general 
issues related to the submission of postmarket medical device reports 
(MDRs) in electronic format. Elsewhere in this issue of the Federal 
Register, FDA is publishing a proposed rule to require that 
manufacturers, importers, and user facilities submit most MDRs to the 
agency in electronic format.

DATES:  Although you can comment on any guidance at any time (see 21 
CFR 10.115 (g)(5)), to ensure that the agency considers your comment on 
this draft guidance before it begins work on the final version of the 
guidance, submit written or electronic comments on the draft guidance 
by November 19, 2009.

ADDRESSES:  Submit written requests for single copies of the draft 
guidance document entitled ``eMDR--Electronic Medical Device 
Reporting'' to the Division of Small Manufacturers, International, and 
Consumer Assistance , Center for Devices and Radiological Health, Food 
and Drug Administration, 10903 New Hampshire Ave., Building 66, rm. 
4613, Silver Spring, MD 20993-0002. Send one self-addressed adhesive 
label to assist that office in processing your request, or fax your 
request to 301-847-8149. See the SUPPLEMENTARY INFORMATION section for 
information on electronic access to the guidance. Submit written 
comments concerning this draft guidance to the Division of Dockets 
Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane, 
rm. 1061, Rockville, MD 20852. Submit electronic comments to https://www.regulations.gov. Identify comments with the docket number found in 
brackets in the heading of this document.

FOR FURTHER INFORMATION CONTACT: Howard Press, Center for Devices and 
Radiological Health, Food and Drug Administration, 10903 New Hampshire 
Ave., Building 66, rm. 3320, Silver Spring, MD 20993-0002, 301-796-
6087.

SUPPLEMENTARY INFORMATION:

I. Background

    The draft guidance document provides information related to the 
submission of postmarket MDRs in electronic format, including technical 
information. The information provided in the draft guidance document is 
intended to help reporters prepare the MDR for electronic submission in 
a way that would satisfy the requirements of FDA's proposed electronic 
Medical device reporting regulation that is published elsewhere in this 
issue of the Federal Register.

II. Significance of Guidance

    This draft guidance is being issued consistent with FDA's good 
guidance practices regulation (21 CFR 10.115). The draft guidance, when 
finalized will represent the agency's current thinking on electronic 
medical device reporting (eMDR). It does not create or confer any 
rights for or on any person and does not operate to bind FDA or the 
public. An alternative approach may be used if such approach satisfies 
the requirements of the applicable statute and regulations.

III. Electronic Access

    Persons interested in obtaining a copy of the draft guidance may do 
so by using the Internet. To receive an electronic copy of ``eMDR--
Electronic Medical Device Reporting'' you may either send an e-mail 
request to dsmica@fda.hhs.gov or send a fax request to 240-276-3151 to 
receive a hard copy. Please use the document number 1679 to identify 
the guidance you are requesting.
    The Center for Devices and Radiological Health (CDRH) maintains an 
entry on the Internet for easy access to information including text, 
graphics, and files that may be downloaded to a personal computer with 
Internet access. Updated on a regular basis, the CDRH home page 
includes device safety alerts, Federal Register reprints, information 
on premarket submissions (including lists of approved applications and 
manufacturers' addresses), small manufacturer's assistance, information 
on video conferencing and electronic submissions, Mammography Matters, 
and other device-oriented information. The CDRH Web site may be 
accessed at https://www.fda.gov/cdrh. A search capability for all CDRH 
guidance documents is available at https://www.fda.gov/cdrh/guidance.html. Guidance documents are also available on the Division of 
Dockets Management Internet site at https://www.regulations.gov.

IV. Paperwork Reduction Act of 1995

    This draft guidance refers to proposed collections of information 
described in FDA's proposed rule on medical device reporting, 
electronic submission requirements, published elsewhere in this issue 
of the Federal Register. The proposed collections of information in the 
proposed rule are subject to review by the Office of Management and 
Budget (OMB) under the Paperwork Reduction Act of 1995 (PRA) (44 U.S.C. 
3501-3520). In accordance with the proposed medical device regulation, 
medical device manufacturers, importers, and user facilities would be 
required to submit MDRs to FDA, to maintain records, and may also seek 
exemption or variance from these requirements. Manufacturers, importer, 
and user facilities are currently submitting paper MDR reports on FDA 
Form 3500 A, for which the existing information collection requirements 
under 21 CFR part 803 are approved under OMB control number 0910-0437. 
The changes to the burden associated with this proposed rule have been 
sent to OMB as a revision to OMB control number 0910-0437 for review 
under section 307(d) of the PRA.

V. Comments

    Interested persons may submit to the Division of Dockets Management 
(see ADDRESSES), written or electronic comments regarding this 
document. Submit a single copy of electronic comments or two paper 
copies of any mailed comments, except that individuals may submit one 
paper copy. Comments are to be identified with the docket number found 
in brackets in the heading of this document. Received comments may be 
seen in the Division of Dockets Management between 9 a.m. and 4 p.m., 
Monday through Friday.

    Dated: August 11, 2009.
Jeffrey Shuren,
Associate Commissioner for Policy and Planning.
[FR Doc. E9-19681 Filed 8-20-09; 8:45 am]
BILLING CODE 4160-01-S
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.